Skip to main content

Voyager Therapeutics, Inc.

VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001640266

No open-market purchases or sales by Voyager Therapeutics, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $122.7M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Voyager Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
132
+26 vs. Q4 2023
Shares held
35.6M
+8.66M (+32.2%) vs. Q4 2023
Total value
$331.1M
+$104.0M (+45.8%) vs. Q4 2023
New holders
33
57 more added
Sold out
7
28 more reduced

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VYGR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 132 institutions
Q1 2021: 101 institutionsQ2 2021: 78 institutionsQ3 2021: 69 institutionsQ4 2021: 59 institutionsQ1 2022: 70 institutionsQ2 2022: 78 institutionsQ3 2022: 69 institutionsQ4 2022: 70 institutionsQ1 2023: 82 institutionsQ2 2023: 106 institutionsQ3 2023: 111 institutionsQ4 2023: 107 institutionsQ1 2024: 132 institutionsQ2 2024: 127 institutionsQ3 2024: 128 institutionsQ4 2024: 133 institutionsQ1 2025: 116 institutionsQ2 2025: 113 institutionsQ3 2025: 117 institutionsQ4 2025: 125 institutionsQ1 2026: 135 institutionsQ2 2026: 135 institutions
Value heldQ1 2024: $331.1M
Q1 2021: $125.7MQ2 2021: $96.8MQ3 2021: $58.6MQ4 2021: $51.3MQ1 2022: $171.3MQ2 2022: $142.3MQ3 2022: $142.9MQ4 2022: $146.2MQ1 2023: $183.8MQ2 2023: $307.7MQ3 2023: $211.2MQ4 2023: $227.5MQ1 2024: $331.1MQ2 2024: $301.6MQ3 2024: $205.9MQ4 2024: $196.2MQ1 2025: $117.4MQ2 2025: $103.1MQ3 2025: $141.1MQ4 2025: $132.6MQ1 2026: $129.4MQ2 2026: $122.7M
Institutions holding VYGR and their total value by quarter
QuarterHoldersValue
Q2 2026135$122.7M
Q1 2026135$129.4M
Q4 2025125$132.6M
Q3 2025117$141.1M
Q2 2025113$103.1M
Q1 2025116$117.4M
Q4 2024133$196.2M
Q3 2024128$205.9M
Q2 2024127$301.6M
Q1 2024132$331.1M
Q4 2023107$227.5M
Q3 2023111$211.2M
Q2 2023106$307.7M
Q1 202382$183.8M
Q4 202270$146.2M
Q3 202269$142.9M
Q2 202278$142.3M
Q1 202270$171.3M
Q4 202159$51.3M
Q3 202169$58.6M
Q2 202178$96.8M
Q1 2021101$125.7M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Voyager Therapeutics, Inc.; share changes are against Q4 2023.

Institutions holding VYGR in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
First Trust Advisors LP138,129$1.29M0.00%+52,290+60.9%Added
Massachusetts Financial Services Co138,707$1.29M0.00%+27,781+25.0%Added
TD Asset Management Inc161,928$1.51M0.00%+28,426+21.3%Added
Bridgeway Capital Management, LLC179,771$1.67M0.03%−1,025−0.6%Reduced
Ikarian Capital, LLC180,857$1.68M0.46%−125,000−40.9%Reduced
Wellington Management Group LLP204,029$1.90M0.00%+204,029New
D. E. Shaw & Co., Inc.233,989$2.18M0.00%−172,055−42.4%Reduced
Bank of New York Mellon Corp250,131$2.33M0.00%−2,776−1.1%Reduced
Kestra Advisory Services, LLC256,449$2.39M0.02%+40,368+18.7%Added
Fiduciary Trust Co259,397$2.41M0.04%00.0%Unchanged
Morgan Stanley282,160$2.63M0.00%+38,782+15.9%Added
Woodline Partners LP300,000$2.79M0.03%+300,000New
Globeflex Capital L P309,508$2.88M0.28%−21,782−6.6%Reduced
JPMorgan Chase & Co316,655$2.95M0.00%−6,873−2.1%Reduced
Bank of America Corp354,443$3.30M0.00%+346,741+4,502.0%Added
Goldman Sachs Group Inc381,709$3.55M0.00%+201,684+112.0%Added
Northern Trust Corp389,816$3.63M0.00%+74,850+23.8%Added
Acadian Asset Management LLC459,850$4.28M0.01%+42,029+10.1%Added
Federated Hermes, Inc.551,576$5.14M0.01%00.0%Unchanged
Vestal Point Capital, LP600,000$5.59M0.46%+600,000New
American Century Companies Inc769,673$7.17M0.00%+299,444+63.7%Added
AQR Capital Management LLC793,634$7.39M0.01%+154,347+24.1%Added
Geode Capital Management, LLC972,364$9.05M0.00%+293,486+43.2%Added
Price T Rowe Associates Inc1,041,930$9.70M0.00%+37,144+3.7%Added
Erste Asset Management GmbH1,058,378$9.90M0.13%00.0%Unchanged
Dimensional Fund Advisors LP1,105,555$10.3M0.00%+173,324+18.6%Added
State Street Corp1,749,168$16.3M0.00%+1,129,356+182.2%Added
Farallon Capital Management, L.L.C.2,292,000$21.3M0.13%+1,000,000+77.4%Added
Vanguard Group Inc3,231,698$30.1M0.00%+702,030+27.8%Added
EcoR1 Capital, LLC3,917,546$36.5M0.93%+66,039+1.7%Added
BlackRock Inc.4,397,444$40.9M0.00%+1,764,765+67.0%Added
Armistice Capital, LLC4,672,000$43.5M1.16%+436,000+10.3%Added
CWM Advisors, LLC0$00.00%−95,002−100.0%Sold out
Mirae Asset Global Investments Co., Ltd.0$00.00%−16,910−100.0%Sold out
HSBC Holdings PLC0$00.00%−14,322−100.0%Sold out
AJOVista, LLC0$00.00%−4,573−100.0%Sold out
Benjamin F. Edwards & Company, Inc.0$00.00%−2,220−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,100−100.0%Sold out
Group One Trading, L.P.0$00.00%−135−100.0%Sold out
Putnam Investments LLC––––Not filed